Enhance home walking and balance
- Trial ID
- NCT06617884
- Official Title
- Comparison of Two Home-based Gait and Balance Trainings With Different Training Frequencies in Patients With Parkinson's Disease and Ataxia
- Goal
- Enhance home walking and balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Forschungszentrum Juelich
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Ataxia, Parkinson Disease
- Interventions
- Gait and balance training
Plain-Language Summary
Researchers are testing whether different schedules of home-based gait and balance exercises can improve walking, stability, and daily mobility in people with Parkinson's disease or cerebellar ataxia, and whether one frequency is more effective at reducing fall risk. Participants follow guided at-home training that targets stepping, coordination, timing, and leg strength to retrain balance responses and gait patterns through repetition and motor learning, this is a non-drug approach meant to complement medications like levodopa rather than replace them. Adults 18 to 75 with a clinical diagnosis of idiopathic Parkinson's syndrome or cerebellar ataxia who can walk at least four meters at home are eligible, while those with frequent falls (one or more per week), other major motor-impacting illnesses, severe psychiatric disease, addiction, poor general health, or inability to consent are excluded; Parkinson's participants must be able to be measured during their on-medication phase.
Locations
- Universitätsklinikum Düsseldorf, Institut für Klinische Neurowissenschaften und Medizinische Psychologie, Düsseldorf, North Rhine-Westphalia, Germany
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Gait and balance training. Researchers are testing whether different schedules of home-based gait and balance exercises can improve walking, stability, and daily mobility in people with Parkinson's disease or cerebellar ataxia, and whether one frequency is more effective at reducing fall risk. Participants follow guided at-home training that targets stepping, coordination, timing, and leg strength to retrain balance responses and gait patterns through repetition and motor learning, this is a non-drug approach meant to complement medications like levodopa rather than replace them. Adults 18 to 75 with a clinical diagnosis of idiopathic Parkinson's syndrome or cerebellar ataxia who can walk at least four meters at home are eligible, while those with frequent falls (one or more per week), other major motor-impacting illnesses, severe psychiatric disease, addiction, poor general health, or inability to consent are excluded; Parkinson's participants must be able to be measured during their on-medication phase.
- Who can participate?
- Participants must be between 18 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 11 months.